Clinical Trials Logo

Clinical Trial Summary

The study is a multi-center, randomized, open, and parallel study. Approximately 958 subjects will be enrolled in 16 sites. The random number table will be adopted to conduct cluster randomization per township hospital/community health service center. Patients will be randomized 1:1 to receive blood pressure management in Internet medical model or Conventional medical model. After follow-ups of 3 months and 6 months, the blood pressure in each group will be observed and compared.


Clinical Trial Description

Protocol Title:A Comparative Study on Internet Medical Models and Conventional Medical Models for the Management of Patients with Hypertension in China Study Indication:Hypertension Number of Site:16sites Study Duration (from the initiation of the first site to the end of the follow-up for the last subject): 12 months Duration of Treatment and Management: 6 months Planned Number of Subjects:958 subjects, 479 in each group(blood pressure management in Internet medical model, Conventional medical model) Internet Medical Model:Using Internet blood pressure management model: home blood pressure self-monitoring + Internet diagnosis + Maintained or adjusted anti-hypertension drug(s) treatment.

Conventional Medical Model:Using Conventional blood pressure management model: home blood pressure monitoring + face-to-face diagnosis in clinic + Maintained or adjusted anti-hypertension drug(s) treatment.

Inclusion Criteria:

1. Male or female, 45 to 75 years old (including 45and 75 years);

2. Two measurements of resting systolic blood pressure ≥ 140mmHg and/or diastolic blood pressure ≥ 90mmHg on different days during screening;

3. Female subjects of child-bearing potential who are willing to adopt one of the following methods for contraception during the study:

- Oral contraceptive, either combined or progestogen alone.

- Injectable progestogen.

- Implants of levonorgestrel.

- Oestrogenic vaginal ring.

- Percutaneous contraceptive patches.

- Intrauterine device or intrauterine system showing that the expected failure rate is less than 1% per year as stated in the product label.

- Double barrier method: condom and an occlusive cap (diaphragm or cervical/vault caps) with a vaginal spermicidal agent (foam/gel/film/cream/suppository).

4. Subjects who can understand and perform home blood pressure monitoring as required by the study;

5. Subjects who voluntarily participate in the study and sign informed consent form.

Exclusion Criteria:

1. Two measurements of resting systolic blood pressure ≥ 180mmHg and/or diastolic blood pressure ≥ 110mmHg on different days during screening;

2. Subjects with the history of cerebral stroke within 6 months prior to screening;

3. Subjects with the history of myocardial infarction within 6 months prior to screening;

4. Subjects with the history of heart failure;

5. Subjects with the history of atrial fibrillation;

6. Subjects with the history of coronary artery revascularization;

7. Subjects with other serious diseases, such as tumor;

8. Subjects diagnosed as the secondary hypertension;

9. Subjects with congenital or acquired organic heart disease;

10. Pregnant or lactant subjects;

11. Subjects with severe mental disease;

12. Subjects with abnormal liver and renal function: ALT or AST>2 X upper limit value; Or creatinine > 2X upper limit value

13. Subjects who were previously diagnosed with diabetes that is currently poorly controlled: FBG>10mmol/L;

14. Subjects who are unable to conduct blood pressure self-test;

15. The subject has any other known condition at screening that would compromise subject safety, might affect life expectancy, or making it difficult to successfully manage and follow the subject according to the protocol.

Efficacy Evaluations:

Primary Efficacy Endpoints:

- Blood pressure control rate of subjects in the two groups at Month 6 Secondary Efficacy Endpoints:

- Blood pressure control rate of subjects in the two groups at Month 3

- Blood pressure value of subjects in the two groups at Month 3 and Month 6

- Change of blood pressure of subjects in the two groups at Month 3 and Month 6

- Variability of blood pressure of subjects in the two groups at Month 3 and Month 6

- Treatment compliance of subjects in the two groups at Month 3 and Month 6

- Medical expense of subjects in the two groups at Month 3 and Month 6

- Treatment satisfaction of subjects in the two groups at Month 3 and Month 6 ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03527563
Study type Interventional
Source China Cardiovascular Association
Contact yong huo, master
Phone 13901333060
Email drhuoyong@163.com
Status Not yet recruiting
Phase N/A
Start date March 2019
Completion date December 2019

See also
  Status Clinical Trial Phase
Terminated NCT04591808 - Efficacy and Safety of Atorvastatin + Perindopril Fixed-Dose Combination S05167 in Adult Patients With Arterial Hypertension and Dyslipidemia Phase 3
Recruiting NCT04515303 - Digital Intervention Participation in DASH
Completed NCT05433233 - Effects of Lifestyle Walking on Blood Pressure in Older Adults With Hypertension N/A
Completed NCT05491642 - A Study in Male and Female Participants (After Menopause) With Mild to Moderate High Blood Pressure to Learn How Safe the Study Treatment BAY3283142 is, How it Affects the Body and How it Moves Into, Through and Out of the Body After Taking Single and Multiple Doses Phase 1
Completed NCT03093532 - A Hypertension Emergency Department Intervention Aimed at Decreasing Disparities N/A
Completed NCT04507867 - Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III N/A
Recruiting NCT05529147 - The Effects of Medication Induced Blood Pressure Reduction on Cerebral Hemodynamics in Hypertensive Frail Elderly
Recruiting NCT05976230 - Special Drug Use Surveillance of Entresto Tablets (Hypertension)
Completed NCT06008015 - A Study to Evaluate the Pharmacokinetics and the Safety After Administration of "BR1015" and Co-administration of "BR1015-1" and "BR1015-2" Under Fed Conditions in Healthy Volunteers Phase 1
Completed NCT05387174 - Nursing Intervention in Two Risk Factors of the Metabolic Syndrome and Quality of Life in the Climacteric Period N/A
Completed NCT04082585 - Total Health Improvement Program Research Project
Recruiting NCT05121337 - Groceries for Black Residents of Boston to Stop Hypertension Among Adults Without Treated Hypertension N/A
Withdrawn NCT04922424 - Mechanisms and Interventions to Address Cardiovascular Risk of Gender-affirming Hormone Therapy in Trans Men Phase 1
Active, not recruiting NCT05062161 - Sleep Duration and Blood Pressure During Sleep N/A
Completed NCT05087290 - LOnger-term Effects of COVID-19 INfection on Blood Vessels And Blood pRessure (LOCHINVAR)
Not yet recruiting NCT05038774 - Educational Intervention for Hypertension Management N/A
Completed NCT05621694 - Exploring Oxytocin Response to Meditative Movement N/A
Completed NCT05688917 - Green Coffee Effect on Metabolic Syndrome N/A
Recruiting NCT05575453 - OPTIMA-BP: Empowering PaTients in MAnaging Blood Pressure N/A
Completed NCT03875768 - Nourish: A Digital Health Program to Promote the DASH Eating Plan Among Adults With High Blood Pressure N/A